<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BRN</journal-id>
<journal-id journal-id-type="hwp">spbrn</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Res Nurs</journal-id>
<journal-title>Biological Research For Nursing</journal-title>
<issn pub-type="ppub">1099-8004</issn>
<issn pub-type="epub">1552-4175</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1099800411430380</article-id>
<article-id pub-id-type="publisher-id">10.1177_1099800411430380</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Measurement of MicroRNA</article-title>
<subtitle>A Regulator of Gene Expression</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Flowers</surname>
<given-names>Elena</given-names>
</name>
<degrees>RN, MS, MAS, PhDc</degrees>
<xref ref-type="aff" rid="aff1-1099800411430380">1</xref>
<xref ref-type="corresp" rid="corresp1-1099800411430380"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Froelicher</surname>
<given-names>Erika Sivarajan</given-names>
</name>
<degrees>RN, PhD, FAAN</degrees>
<xref ref-type="aff" rid="aff1-1099800411430380">1</xref>
<xref ref-type="aff" rid="aff2-1099800411430380">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aouizerat</surname>
<given-names>Bradley E.</given-names>
</name>
<degrees>PhD, MAS</degrees>
<xref ref-type="aff" rid="aff1-1099800411430380">1</xref>
<xref ref-type="aff" rid="aff3-1099800411430380">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1099800411430380"><label>1</label>Department of Physiologic Nursing, School of Nursing, University of California, San Francisco, CA, USA</aff>
<aff id="aff2-1099800411430380"><label>2</label>Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA, USA</aff>
<aff id="aff3-1099800411430380"><label>3</label>Institute for Human Genetics, University of California, San Francisco, CA, USA</aff>
<author-notes>
<corresp id="corresp1-1099800411430380">Elena Flowers, RN, MS, MAS, PhDc, Department of Physiologic Nursing, School of Nursing, University of California, San Francisco, 2 Koret Way, #N611Y, San Francisco, CA 94143, USA. Email: <email>eflowers@ucsf.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>15</volume>
<issue>2</issue>
<fpage>167</fpage>
<lpage>178</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>MicroRNAs (miRs) are epigenetic regulators of messenger RNAs' (mRNA) expression of polypeptides. As such, miRs represent an intriguing mechanism by which gene–environment interactions are hypothesized to occur on the level of epigenetic control over gene expression. In addition to promising findings from in vitro studies indicating that miRs have the potential to function as therapeutic agents in modifying the course of pathophysiologic conditions, recent human studies revealed changes in miR expression patterns in response to behavioral interventions. The authors provide an overview of how miRs are preserved and isolated from other genetic material and describe commonly used methods for measuring miR in the research setting, including Northern blot, polymerase chain reaction, and microarray. The authors also introduce bioinformatic approaches to analysis of high-throughput miR expression and techniques used to create predictive models of miR-mRNA binding to describe possible physiologic pathways affected by specific miRs.</p>
</abstract>
<kwd-group>
<kwd>microRNA</kwd>
<kwd>epigenetics</kwd>
<kwd>measurement</kwd>
<kwd>microarray</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Gene–environment interactions are increasingly recognized as an important mechanism in the development and progression of all disease conditions, ranging from common, complex disease (e.g., cardiovascular disease, type 2 diabetes) to mental health disorders (e.g., schizophrenia, antisocial personality disorder) to trauma (e.g., gunshot wounds). The theory of gene–environment interaction posits that the expression and effects of the individual genome can be modified by environmental stimuli. These interactions can occur at the gene level, when specific risk or protective alleles are present and interact with environmental factors, or at the epigenetic<sup><xref ref-type="fn" rid="fn1-1099800411430380">
1
</xref></sup> level, when the expression of genes controlling normal physiologic processes is up- or downregulated in response to environmental factors.</p>
<p>A primary purpose of studying gene–environment interactions is to determine the public health impact of individual risk factors within a specific population, facilitating development of targeted interventions to maximize health and minimize disease. Importantly, however, population-based interventions to target risk factors for adverse health outcomes often show less than desirable effectiveness. Improved risk stratification and early detection of risk may help to prevent onset of disease and prevent secondary outcomes. While clinical outcomes associated with interventions to change lifestyle and behavioral characteristics have been well described, the mechanisms by which health outcomes are modified are not fully understood. A deeper understanding of the mechanisms by which risk factors act, including epigenetic modification of gene expression, may guide therapies and interventions in order to increase efficacy. This type of health promotion and disease prevention is a primary component of nursing practice.</p>
<p>MicroRNAs (miRs), a recently described epigenetic phenomenon, regulate gene expression. MiR activity regulates numerous disease conditions in humans, including cardiovascular and metabolic diseases, cancers, and sequelae from trauma. Insights from miR studies have confirmed previously hypothesized physiologic mechanisms and shed light on possible new pathways of disease. MiR activity often reflects change in a physiologic condition before overt effects are observed in the clinical setting and may serve as a sensitive biomarker for these conditions. Importantly, miR activity is highly dynamic and responds to environmental stimuli, resulting in alterations of gene expression. This characteristic of miR activity makes it particularly appealing for further study as a marker for response to therapies and interventions, an important and promising frontier in nursing research.</p>
<p>Our purpose in this article is to describe methods for detection and quantification of miR. Reliable and valid methods for measurement of miR are available in the research setting. MiR is a short, single-strand sequence of nucleotides found most commonly in the cytoplasm of cells. MiR measurement in humans requires access to a source of cells, from which miRs are isolated and preserved to ensure stability during storage prior to measurement. Methods of accessing the miR sources can be noninvasive (e.g., with saliva) or invasive (e.g., with neural tissue). We describe three methods for detection and quantification of specific miR species: Northern blot, targeted polymerase chain reaction (PCR), and microarray. Simultaneous detection and quantification of numerous miR species are possible with high-throughput PCR and microarray methods. These methods result in vast amount of data, presenting analytic and computational challenges. Thus, we also briefly present methods for decreasing the likelihood of false positives while maintaining high sensitivity and clustering algorithm methods to allow for rational categorization and interpretation of large amount of data.</p>
<sec id="section1-1099800411430380">
<title>miR</title>
<p>MiRs are short sequences (18–25 nucleotides) of RNA found in the cellular cytoplasm. MiRs originate from the transcription of deoxyribonucleic acid (DNA) in the cell nucleus (<xref ref-type="fig" rid="fig1-1099800411430380">Figure 1</xref>
). The initial single-stranded product that forms a stem–loop structure that includes a double-strand region is modified by a series of enzymatic reactions into the mature single-strand miR molecule. Mature miRs bind to stabilizing proteins to form structures called ribonucleoprotein miR–induced silencing complexes, which collect in the cytoplasm in structures termed p-bodies. MiRs exert their regulatory effects by binding to messenger RNA (mRNA), inhibiting translation of mRNA into polypeptides.</p>
<fig id="fig1-1099800411430380" position="float">
<label>Figure 1.</label>
<caption>
<p>MicroRNA (miR) processing in the nucleus and cytoplasm, which portrays the origination of miR from deoxyribonucleic acid (DNA) in the nucleus, modification into mature miR, and activity in the cytoplasm.</p>
</caption>
<graphic xlink:href="10.1177_1099800411430380-fig1.tif"/>
</fig>
<p>MiRs are highly dynamic, showing variable expressivity over time, which is associated with variable concentrations of protein products regulated by miR. The triggers of variation in miR expression are not fully understood, however, changes to both the intracellular and the external environment appear to have important effects. This property makes miR an important candidate for studies of gene–environment interactions. Studies of miR activity in cells isolated from the pancreases of mice exposed to a high glucose stimulus showed threefold changes in individual miR’s expression (<xref ref-type="bibr" rid="bibr56-1099800411430380">Tang, Muniappan, Tang, &amp; Ozcan, 2009</xref>), and similarly, rats fed a high-fat diet and overweight humans exhibit elevations in concentrations of specific miRs compared to normal-weight controls (<xref ref-type="bibr" rid="bibr59-1099800411430380">Vinciguerra et al., 2009</xref>). Healthy humans exhibit changes in the expression of miRs in circulating neutrophils following an exercise intervention (<xref ref-type="bibr" rid="bibr45-1099800411430380">Radom-Aizik, Zaldivar, Oliver, Galassetti, &amp; Cooper, 2010</xref>). These findings further support the role of miR as a mediator of gene expression changes in response to the environment and substantiate the possibility of using miR to measure the effects of behavioral changes, permitting a deeper understanding of the mechanisms by which behavioral changes function.</p>
<p>Studies of the role of miR regulation in disease most commonly incorporate two aims. The first is to detect which of several hundred known miR species are present in a given tissue, in effect determining the miR fingerprint that characterizes a specific tissue. The type and number of miRs present depends on the physiologic needs of the tissue, and this fingerprint differs between individuals with normal physiologic function and individuals with a pathologic condition predisposing to or causing a disease. Therefore, the second aim is to quantify the level of prevalent miR species so that comparative analysis between individuals can be performed. In order to accomplish these aims, the researcher must first obtain tissue. The choice of tissue source depends on the disease condition of interest and feasibility of access. The extracted tissue must then be preserved, and the miRs must be isolated from other cellular and genetic material before detection and quantification.</p>
</sec>
<sec id="section2-1099800411430380">
<title>Tissue Sources of miR</title>
<p>The central dogma of molecular biology (<xref ref-type="fig" rid="fig2-1099800411430380">Figure 2</xref>
) tells us that genes exist as sequences of nucleotides that are transcribed to an intermediate messenger molecule aptly called mRNA, which is then translated into amino acids and synthesized into polypeptides, the building blocks of proteins. However, not all genes are expressed at all times. Some genes, known as housekeeping genes, are essential to cellular function, regardless of cell type, whereas other genes encode for specific polypeptides forming proteins only needed in certain physiologic states or tissues. Further, the function of some genes is to express RNA (including miR) that is never translated into polypeptides. For example, some genes encode for the machinery necessary to perform transcription and translation. A form of RNA called transfer RNA (tRNA) binds individual amino acids and facilitates polypeptide synthesis during transcription of mRNA. Ribosomal RNA (rRNA) is another helper in the process of transcription, and both tRNA and rRNA are created by the process of transcription and translation of their specific genes. In contrast, melanin, a protein that causes skin pigmentation, is continually expressed in dermal cells but is not expressed in neural cells where its function would be inappropriate. We observe varying degrees of skin pigmentation between different ethnic and geographic populations, suggesting that melanin expression is variable among individuals and is dependent on some degree of predetermined genetic control as well as environmental exposure in the form of ultraviolet radiation that composes sunlight. Melanin, then, is an example of dynamic gene expression that is tissue specific, as well as an interaction between genetic predisposition and the environment.</p>
<fig id="fig2-1099800411430380" position="float">
<label>Figure 2.</label>
<caption>
<p>Central dogma of molecular biology, which depicts the process by which deoxyribonucleic acid (DNA) is converted into RNA and polypeptides, the building blocks of amino acids and proteins.</p>
</caption>
<graphic xlink:href="10.1177_1099800411430380-fig2.tif"/>
</fig>
<p>Because of the specific nature of gene expression associated with discrete physiologic pathways, studies of gene expression require access to tissues in which these pathways are occurring. Early investigation of gene expression and epigenetic mechanisms regulating gene expression are generally performed in cultured cells in vitro followed by studies in animal models in tightly controlled experimental settings. For numerous disease conditions, miR expression varies within an organism by tissue type (<xref ref-type="bibr" rid="bibr22-1099800411430380">Ikeda et al., 2007</xref>; <xref ref-type="bibr" rid="bibr26-1099800411430380">Kloting et al., 2009</xref>; <xref ref-type="bibr" rid="bibr29-1099800411430380">Lagos-Quintana et al., 2002</xref>; <xref ref-type="bibr" rid="bibr33-1099800411430380">Liu &amp; Kohane, 2009</xref>; <xref ref-type="bibr" rid="bibr44-1099800411430380">Poy et al., 2004</xref>). Translation of these findings to human pathophysiology is often limited by feasibility of access to tissues involved in specific pathways of interest. For example, studies of genes expressed in heart failure can be performed on cardiomyocyte cell lines in vitro, but translation to human studies requires cardiac biopsy, involving extremely invasive cardiac catheterization. In some settings, cardiac biopsies may be performed on individuals with heart failure; however, it would be ethically inappropriate to expose healthy controls to the same procedure, making comparative analysis of cases and controls in order to determine pathophysiologic miR profiles infeasible.</p>
<p>The practical and ethical challenges associated with accessing tissue sources limit the clinical utility of measuring RNA. However, most disease conditions involve signaling, increased systemic inflammation, and/or physiologic stress in the peripheral circulation. Preliminary data indicate that plasma measurements of miR expression can effectively detect differences between diseased and healthy individuals for a number of disease conditions.</p>
<p>Investigators in studies of numerous disease conditions have quantified miR expression in blood. MiRs in peripheral blood can be isolated from leukocytes, which may capture miR function in immune activity. However, miRs have also been detected in the plasma component of blood (<xref ref-type="bibr" rid="bibr10-1099800411430380">Chen et al., 2008</xref>). Measurement studies of plasma demonstrated that miR is stable and reproducible using common RNA quantification methods (<xref ref-type="bibr" rid="bibr10-1099800411430380">Chen et al., 2008</xref>). Much of the work describing miR expression in plasma to date has been performed on humans and other animals with cancer, and researchers have observed differential expression of miRs between humans with and without cancer (<xref ref-type="bibr" rid="bibr36-1099800411430380">Lodes et al., 2009</xref>). In one example, investigators observed that miR expression in plasma differed between individuals with and without pancreatic cancer, and a panel of four miR species exhibited a sensitivity of 64% and sensitivity of 89% for detecting pancreatic cancer compared to controls (<xref ref-type="bibr" rid="bibr60-1099800411430380">Wang et al., 2009</xref>). Preliminary research has shown that miR expression also differs in the plasma of humans with disease conditions other than cancer (<xref ref-type="bibr" rid="bibr34-1099800411430380">Liu et al., 2009</xref>; <xref ref-type="bibr" rid="bibr54-1099800411430380">Tan et al., 2009</xref>; <xref ref-type="bibr" rid="bibr58-1099800411430380">Vasilescu et al., 2009</xref>), including diabetes (<xref ref-type="bibr" rid="bibr10-1099800411430380">Chen et al., 2008</xref>). <xref ref-type="bibr" rid="bibr10-1099800411430380">Chen et al. (2008)</xref> observed unique expression of 17 (serum) and 27 (blood cell) miRs in individuals with diabetes compared to healthy controls. They also found that the serum miR expression better differentiated diabetic individuals from healthy controls than miR expression from blood cells. Based on the studies cited above, blood-based measurement of miR expression appears to be feasible and shows promise for detection and discrimination of disease states.</p>
</sec>
<sec id="section3-1099800411430380">
<title>Preservation</title>
<p>MiR is an unstable molecule, prone to degradation by ubiquitous ribonuclease enzymes that rapidly degrade RNA. As a result, studies of RNA, including miR, require immediate preservation of tissue specimens in order to accurately capture miR levels present at the time of sample collection. Common preservation techniques include freezing complete specimens in liquid nitrogen or on dry ice or placing the specimen in an aqueous salt buffer, which precipitates ribonuclease enzymes, preventing degradation of RNA, including miR (<xref ref-type="bibr" rid="bibr1-1099800411430380">Allewell &amp; Sama, 1974</xref>). Freezing methods have limitations including the need for specialized equipment and resources, trained personnel, and cold storage. Salt-buffer preservation methods are simple to perform and have shown comparable results from RNA isolation and quantification methods when compared to fresh-frozen methods (<xref ref-type="bibr" rid="bibr6-1099800411430380">Brown &amp; Smith, 2009</xref>; <xref ref-type="bibr" rid="bibr15-1099800411430380">Florell et al., 2001</xref>; <xref ref-type="bibr" rid="bibr40-1099800411430380">Mutter et al., 2004</xref>). Salt-buffer-preserved RNA specimens can be stored under standard refrigeration (4 °C) for up to 30 days or indefinitely at −20 °C or −80 °C (<xref ref-type="bibr" rid="bibr4-1099800411430380">Ambion, 2008b</xref>).</p>
</sec>
<sec id="section4-1099800411430380">
<title>Isolation</title>
<p>Commercial kits are widely used for isolation of total RNA from tissues and other materials. Briefly, the methods employed by these kits are as follows: (a) incubation of tissue with a lysis buffer to disrupt cell membranes, (b) extraction of RNA with acid guanidinium thiocyanate-phenol-chloroform reagent (commercially available as Trizol [Invitrogen, Carlsbad, CA] or TRI-Reagent [Sigma-Aldrich, St. Louis, MO]), (c) washing of the precipitate with an ethanol solution, (d) centrifugation in a spin column tube containing a filter to isolate RNA precipitate, and (e) elution of the precipitate in ribonuclease-free water resulting in an aqueous solution of isolated RNA (<xref ref-type="bibr" rid="bibr3-1099800411430380">Ambion, 2008a</xref>; <xref ref-type="bibr" rid="bibr12-1099800411430380">Chomczynski &amp; Sacchi, 1987</xref>). Extraction of small RNA molecules including miR requires some modification of this procedure by altering the concentration of ethanol wash and using a different column filtration device containing a glass fiber filter (<xref ref-type="bibr" rid="bibr3-1099800411430380">Ambion, 2008a</xref>; <xref ref-type="bibr" rid="bibr38-1099800411430380">Mraz, Malinova, Mayer, &amp; Pospisilova, 2009</xref>). A higher concentration of ethanol renders larger RNA molecules (&gt;200 nucleotides) immobilized and unable to pass through the filter (<xref ref-type="bibr" rid="bibr3-1099800411430380">Ambion, 2008a</xref>). The ethanol concentration of this small RNA-enriched solution is increased again and passed through a second filter, rendering the small RNA immobilized and isolated above the filter. Quantitative analyses of miR expression in fresh compared with properly preserved and stored tissue samples have shown comparable results (<xref ref-type="bibr" rid="bibr38-1099800411430380">Mraz et al., 2009</xref>). Properly isolated and preserved miRs can then be further analyzed in order to detect the presence of and quantify the individual miR species.</p>
</sec>
<sec id="section5-1099800411430380">
<title>Detection and Quantification</title>
<p>In order to investigate the role of miR regulation of gene expression in a given pathological process, it is typically necessary to first determine which of the several hundred individual miR species are present in a specific tissue source. Second, investigators must quantify prevalent miR species in order to compare expression levels between tissue types and between individuals with differing phenotypes. There are three primary methods for detecting and quantifying miR expression: Northern blot, PCR, and microarray. Selection of an appropriate method depends on the aim of the research study and type of data sought for downstream analysis (<xref ref-type="table" rid="table1-1099800411430380">Table 1</xref>
).</p>
<table-wrap id="table1-1099800411430380" position="float">
<label>Table 1.</label>
<caption>
<p>Comparison of MicroRNA (miR) Measurement Methods.</p>
</caption>
<graphic alternate-form-of="table1-1099800411430380" xlink:href="10.1177_1099800411430380-table1.tif"/>
<table>
<thead>
<tr>
<th>Method</th>
<th>Strengths</th>
<th>Weaknesses</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3">Northern blot</td>
<td rowspan="3">Allows for detection of miR size</td>
<td>Requires a large amount of starting material</td>
</tr>
<tr>
<td>Requires stringent oligonucleotide<sup>a</sup> hybridization</td>
</tr>
<tr>
<td>Only semiquantitative; poorest sensitivity and specificity</td>
</tr>
<tr>
<td rowspan="5">Polymerase chain reaction (PCR)</td>
<td>Multiplex simultaneous amplification of several miR species</td>
<td>Targeted study of hypothesized miRs only</td>
</tr>
<tr>
<td>Small amount of starting material required</td>
<td rowspan="4">Specially shaped specific sequence primers required for amplification to occur</td>
</tr>
<tr>
<td>Comparative analysis of quantity of several miRs possible</td>
</tr>
<tr>
<td>Can be automated, decreasing human error</td>
</tr>
<tr>
<td>Improved sensitivity and specificity compared to Northern blot</td>
</tr>
<tr>
<td rowspan="5">Microarray</td>
<td>Multiplex simultaneous amplification of several miR species</td>
<td rowspan="5">Often decreased specificity compared to PCR</td>
</tr>
<tr>
<td>Hypothesis-free study of hundreds of known miR species</td>
</tr>
<tr>
<td>Comparative analysis of quantity of several miRs possible</td>
</tr>
<tr>
<td>Can be automated, decreasing human error</td>
</tr>
<tr>
<td>Improved sensitivity and specificity compared to Northern blot</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1099800411430380">
<p>
<italic>Note.</italic> 
<sup>a</sup>Synthesized short strands of nucleic acids (generally &lt;20 nucleotides in length) designed to be used as probes that will bind to a specific complementary DNA or RNA sequence.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section6-1099800411430380">
<title>Northern Blot</title>
<p>Northern blotting is an electrophoretic method for separating individual RNA molecules on the basis of size, shape, and/or electrical charge and detecting individual RNA sequences using binding to radioactive or chemiluminescent-labeled<sup><xref ref-type="fn" rid="fn2-1099800411430380">
2
</xref></sup> oligonucleotides<sup><xref ref-type="fn" rid="fn3-1099800411430380">
3
</xref></sup> called probes (<xref ref-type="bibr" rid="bibr2-1099800411430380">Alwine, Kemp, &amp; Stark, 1977</xref>; <xref ref-type="bibr" rid="bibr25-1099800411430380">Kevil et al., 1997</xref>; <xref ref-type="bibr" rid="bibr57-1099800411430380">Valoczi et al., 2004</xref>). Isolated RNA is loaded onto a polyacrylamide or agarose gel and placed in a buffer solution (<xref ref-type="bibr" rid="bibr2-1099800411430380">Alwine et al., 1977</xref>; <xref ref-type="bibr" rid="bibr25-1099800411430380">Kevil et al., 1997</xref>). An electrical current is applied to the buffer solution, causing miR molecules to migrate through the gel matrix. The rate of movement depends on the size, shape, and/or electrical charge of each miR. The miRs are then transferred from the gel to a nylon membrane and hybridized to radioactive or chemiluminescent-labeled probes. This property of the probes allows miRs to be visualized and quantified to determine the concentration of each miR species present.</p>
<p>A benefit of Northern blotting is that it allows for not only detection but also quantification of miR size. However, the Northern blotting method requires a large amount of RNA relative to other measurement methods and stringent hybridization of oligonucleotides to enable detection of molecules as small as miRs (<xref ref-type="bibr" rid="bibr37-1099800411430380">Lu et al., 2005</xref>). Because of hybridization limitations, Northern blotting is less sensitive than PCR and microarray methods; however, modifications to oligonucleotides have been shown to increase the sensitivity of Northern blotting without decreasing specificity (<xref ref-type="bibr" rid="bibr57-1099800411430380">Valoczi et al., 2004</xref>). These modifications involve the addition of a “locked” nucleic acid<sup><xref ref-type="fn" rid="fn4-1099800411430380">
4
</xref></sup> to every third nucleotide position in the oligonucleotide. Nonetheless, because of its limitations, Northern blotting is less frequently used compared to alternative methods for detection and quantification or miR.</p>
</sec>
<sec id="section7-1099800411430380">
<title>PCR</title>
<p>PCR is a method for identifying and amplifying a specific nucleotide sequence (<xref ref-type="fig" rid="fig3-1099800411430380">Figure 3</xref>
). PCR works by thermal cycling, or repeatedly heating and cooling target sequences of nucleic acids that have been combined with oligonucleotide primers, DNA polymerase enzyme, and free single nucleotides in a buffered solution (<xref ref-type="bibr" rid="bibr39-1099800411430380">Mullis &amp; Faloona, 1987</xref>). When heated to approximately 95 °C, double-stranded DNA will denature as the bonds holding nucleotide strands together are disrupted (<xref ref-type="bibr" rid="bibr17-1099800411430380">Hartl &amp; Jones, 2005</xref>). When the solution is cooled to approximately 55 °C, these single strands will bind with specially designed primers that are complementary to the sequence of interest. The solution is then heated to approximately 70 °C, and the Thermus aquaticus (<italic>Taq</italic>) polymerase enzyme<sup><xref ref-type="fn" rid="fn5-1099800411430380">
5
</xref></sup> sequentially adds free nucleotides to this newly initiated double strand, elongating it until a full complementary sequence has been created, in effect doubling the number of target nucleic acid sequences present (<xref ref-type="bibr" rid="bibr17-1099800411430380">Hartl &amp; Jones, 2005</xref>; <xref ref-type="bibr" rid="bibr21-1099800411430380">Holland, Abramson, Watson, &amp; Gelfand, 1991</xref>). This process is repeated numerous times (typically 30–45 cycles), resulting in exponential amplification of the target sequence (<xref ref-type="bibr" rid="bibr17-1099800411430380">Hartl &amp; Jones, 2005</xref>). The exact temperatures used for a PCR (i.e., denaturation, annealing, and extension) depend on the nucleotide composition of the primers and the specific enzymes used.</p>
<fig id="fig3-1099800411430380" position="float">
<label>Figure 3.</label>
<caption>
<p>Polymerase chain reaction (PCR). Panel A illustrates the PCR method for amplifying nucleic acids. Panel B highlights aspects of PCR specific to measurement of microRNAs (miRs), including the use of reverse transcriptase enzyme to elongate the complementary deoxyribonucleic acid (DNA) strand and use of stem–loop primers which bind at the 3′ end of the parent strand. Panel C depicts a multiwell plate used for multiplex PCR. Panel D depicts binding of fluorescence-labeled probes used in Thermus aquaticus (<italic>Taq</italic>) polymerase (TaqMan assay by Applied Biosystems, Foster City, CA) quantitative PCR (qPCR) methods and graphic representation of the signal produced during qPCR quantification. Probes consist of a reporter and quencher component: the quencher silences expression of the fluorescence until the probe is digested by <italic>Taq</italic> polymerase during the PCR.</p>
</caption>
<graphic xlink:href="10.1177_1099800411430380-fig3.tif"/>
</fig>
<p>A variation of PCR is reverse transcriptase PCR (RT-PCR), which is performed in order to amplify RNA sequences into a complementary strand of DNA (cDNA). In RT-PCR, 5′ primers<sup><xref ref-type="fn" rid="fn6-1099800411430380">
6
</xref></sup> target the terminal sequence of the RNA molecule to initiate replication. The reverse transcriptase enzyme then adds complementary nucleotides to create a cDNA molecule. Primers used for amplification of miR sequences are often structured in a stem–loop formation in which a portion of the primer folds back and binds to itself, creating a double-stranded molecule (<xref ref-type="bibr" rid="bibr9-1099800411430380">Chen et al., 2005</xref>). This method increases stability by preventing binding between two primers, improving the efficiency of the PCR.</p>
<p>Simultaneous amplification of several unique nucleotide sequences in one PCR is possible with multiplex techniques that include multiple primers targeted toward different sequences of interest. Multiplex PCR enables miR amplification when stem–loop structured primers are used as described above (<xref ref-type="bibr" rid="bibr30-1099800411430380">Lao et al., 2006</xref>; <xref ref-type="bibr" rid="bibr55-1099800411430380">Tang, Hajkova, Barton, Lao, &amp; Surani, 2006</xref>). More recently, researchers have carried out numerous individual PCRs for multiple samples in discrete wells on multiwell plates (e.g., TaqMan low-density array by Applied Biosystems, Foster City, CA). Each well is loaded with starting material (i.e., extracted and isolated RNA) for one sample along with primers, enzymes, nucleotides, and buffer. This method allows for rapid detection and quantification of numerous target sequences from multiple samples simultaneously.</p>
<p>A modification of PCR is real-time or quantitative PCR (qPCR), in which quantification of the number of PCR products can be made at the PCR end point, or the completion of each PCR thermal cycle (<xref ref-type="bibr" rid="bibr11-1099800411430380">Chiang et al., 1996</xref>; <xref ref-type="bibr" rid="bibr16-1099800411430380">Gibson, Heid, &amp; Williams, 1996</xref>; <xref ref-type="bibr" rid="bibr18-1099800411430380">Heid, Stevens, Livak, &amp; Williams, 1996</xref>). qPCR requires the addition of a fluorescently labeled probe that will bind with cDNA PCR products. Measurement of the intensity of fluorescence during each PCR cycle reveals the quantity of cDNA product present. The intensity of the fluorescence signal is compared to a background signal or threshold. Intensity or quantity is quantified by a cycle threshold (<italic>C</italic>
<sub>t</sub>) value, which describes the PCR cycle at which signal intensity of the PCR product exceeds the threshold background signal. A higher concentration of starting target sequence results in a lower <italic>C</italic>
<sub>t</sub>. cDNA quantity can be reported as an absolute or relative value (<xref ref-type="bibr" rid="bibr50-1099800411430380">Schmittgen et al., 2000</xref>). Comparative analysis of <italic>C</italic>
<sub>t</sub> levels between two PCR products can be performed in order to determine the relative values of two target sequences. The mathematical derivation of this calculation is described in detail elsewhere (<xref ref-type="bibr" rid="bibr35-1099800411430380">Livak &amp; Schmittgen, 2001</xref>). qPCR is the method most commonly used in comparative expression studies of miR species. A complete description and protocol for qPCR amplification of RNA sequences can be found elsewhere (<xref ref-type="bibr" rid="bibr42-1099800411430380">Nolan, Hands, &amp; Bustin, 2006</xref>).</p>
<p>With the first application of PCR in miR analysis, researchers described amplification of an miR precursor called pre-miR, finding that detection of these molecules using a fluorescence qPCR method was identical to comparative detection of mature miR using Northern blot analysis (<xref ref-type="bibr" rid="bibr49-1099800411430380">Schmittgen, Jiang, Liu, &amp; Yang, 2004</xref>). This method was validated and also shown to work for multiplex PCR performed on plates containing up to 384 wells in which discrete experiments for individual miR species are performed (<xref ref-type="bibr" rid="bibr23-1099800411430380">Jiang, Lee, Gusev, &amp; Schmittgen, 2005</xref>). In this setting, qPCR amplification of mature miR is highly sensitive and easily performed using widely available instruments (<xref ref-type="bibr" rid="bibr37-1099800411430380">Lu et al., 2005</xref>; <xref ref-type="bibr" rid="bibr47-1099800411430380">Raymond, Roberts, Garrett-Engele, Lim, &amp; Johnson, 2005</xref>; <xref ref-type="bibr" rid="bibr51-1099800411430380">Shi &amp; Chiang, 2005</xref>). qPCR is a useful method for detecting the presence of computationally predicted or validating the presence of previously observed miR. PCR is often considered the gold standard for detection and quantification of miR. Benefits of the PCR method are that creation and amplification of cDNA allows for comprehensive analysis even when the starting quantity of cellular genetic material is limited, as is often the case with miR, and increased sensitivity and specificity compared to Northern blot. Quantification is a particularly important aspect of this method of miR detection, allowing for analysis of comparative expression between tissue types and during various physiologic states.</p>
</sec>
<sec id="section8-1099800411430380">
<title>Microarray</title>
<p>Microarray is a multiplex method for simultaneous detection of numerous target nucleotide sequences. As opposed to PCR, which is often used to identify specific miR sequences of interest, microarray is used to simultaneously detect a large number of miR species present in a sample. The precursor to microarray was the dot-blot method, in which antisense oligonucleotide probes for sequences of interest were bound to a nylon membrane. Researchers used this method in early miR analysis to study miR expression from mouse brain tissue during development (<xref ref-type="bibr" rid="bibr28-1099800411430380">Krichevsky, King, Donahue, Khrapko, &amp; Kosik, 2003</xref>). However, the dot-blot method is limited by poor sensitivity. Improvement on the dot-blot method came with robotic spotting of oligonucleotide probes onto glass slides, often called “chips,” creating a microarray platform with improved precision of placement of antisense oligonucleotides<sup><xref ref-type="fn" rid="fn7-1099800411430380">
7
</xref></sup> (<xref ref-type="bibr" rid="bibr32-1099800411430380">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="bibr61-1099800411430380">Zhao et al., 2006</xref>). In order to perform microarray, cDNA are created for all miR species in a sample using nonspecific primers in a PCR and are fluorescently labeled (<xref ref-type="bibr" rid="bibr32-1099800411430380">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="bibr52-1099800411430380">Shingara et al., 2005</xref>; <xref ref-type="bibr" rid="bibr53-1099800411430380">Sun et al., 2004</xref>). The cDNA is washed over the probe-spotted chips. When a nucleotide sequence match between the probe and an miR sequence is present, the cDNA will hybridize to the probe. Detection of the strength of the fluorescence signal from the hybridized cDNA describes the quantity of cDNA present in the sample, which reflects the number of copies of miR in the original sample (<xref ref-type="bibr" rid="bibr32-1099800411430380">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="bibr53-1099800411430380">Sun et al., 2004</xref>).</p>
<p>Microarray chips for miR analysis most often contain several hundred probes. “Housekeeping” probes are included for quality control. Until recently, the housekeeping probes selected for miR microarray were small noncoding RNAs that are ubiquitously and abundantly expressed across species and tissues. More recently, however, tissue- and species-specific miR have been identified for use as housekeeping probes in microarray analysis (<xref ref-type="bibr" rid="bibr7-1099800411430380">Carlsson et al., 2010</xref>; <xref ref-type="bibr" rid="bibr41-1099800411430380">Neville, Collins, Gloyn, McCarthy, &amp; Karpe, 2011</xref>). The remaining probes are chosen based on known commonly occurring and pathway-specific miR and computationally predicted target miR for a specific physiologic process of interest. Microarray chips for miR analysis containing prespecified miR probes are commercially available. Similarly to PCR, both absolute and relative quantities of miR can be calculated. For absolute detection, the intensity of each individual miR probe signal is compared to signals for oligonucleotides of known abundance (<xref ref-type="bibr" rid="bibr13-1099800411430380">Dudley, Aach, Steffen, &amp; Church, 2002</xref>). In order to compare relative miR quantities between two samples, each is labeled with different color fluorescent dye and washed over the same chip, then signal intensity for each probe location is compared. Until recently, microarray has been limited by decreased sensitivity for absolute quantification compared to PCR. One technique to enhance the capabilities of this method is the use of a universal reference containing oligonucleotides of known concentration in addition to test samples in a microarray (<xref ref-type="bibr" rid="bibr5-1099800411430380">Bissels et al., 2009</xref>). The strength of the microarray method is high-throughput parallel measurement of known miR in comparative analysis in order to generate hypotheses about specific miR species for further study. However, high-throughput also comes with a cost: it limits the sensitivity of the parallel measurements. Targets of interest revealed by microarray analyses should be verified with target-specific and more sensitive methods of quantitation (i.e., qPCR).</p>
</sec>
</sec>
<sec id="section9-1099800411430380">
<title>Bioinformatics</title>
<sec id="section10-1099800411430380">
<title>Comparative Analysis</title>
<p>Typically, miR expression levels are compared between two sources (e.g., cases and controls). In order to compare expression levels of single miR species, which are measured on a continuous scale, between two sources, the Student’s <italic>t</italic> test or two-sample <italic>t</italic> test can be used (<xref ref-type="bibr" rid="bibr43-1099800411430380">Pagano &amp; Gauvreau, 2000</xref>). This test can be performed using mean expression values for an individual case compared to an individual control or averaged expression level for a group of cases compared to a group of controls. This type of analysis is useful for targeted investigation of a specific miR species that appears to be associated with the physiologic function of interest. However, studies of miR expression are often exploratory, and measurement of numerous miR species is performed simultaneously, requiring more complex analytic methods.</p>
<p>Quantitative comparison of relative expression of a large number of miR species requires statistical methods that account for multiple comparisons and can accommodate a large amount of data. When many hypothesis tests are performed simultaneously, as is the case with comparative microarray analysis, a type I error of finding significant differences by chance alone is likely. In order to conclude that statistically meaningful differences in expression between two samples exist, it is necessary to make adjustments to the significance threshold to minimize the likelihood of false positives without increasing the probability of type II errors.<sup><xref ref-type="fn" rid="fn8-1099800411430380">
8
</xref></sup> For microarray analysis, this adjustment is most often accomplished with the establishment of a false discovery rate, a prespecified threshold defining an acceptable proportion of false positives from the total number of significant differences detected. There are several widely used methods for establishing a false discovery rate, including the Benjamini–Hochberg procedure (<xref ref-type="bibr" rid="bibr20-1099800411430380">Hochberg &amp; Benjamini, 1990</xref>) and the Bayesian statistics–based Efron–Tibshirani–Storey procedure (<xref ref-type="bibr" rid="bibr14-1099800411430380">Efron &amp; Tibshirani, 2002</xref>). Mathematical derivation and application of these methods is described in detail elsewhere (<xref ref-type="bibr" rid="bibr14-1099800411430380">Efron &amp; Tibshirani, 2002</xref>; <xref ref-type="bibr" rid="bibr20-1099800411430380">Hochberg &amp; Benjamini, 1990</xref>).</p>
<p>Data analysis methods that organize a large number of data points, known generally as hierarchical clustering, are commonly used in gene expression studies, including miR analyses. Clustering methods have the important feature of pattern detection and creation of data-based structures to accommodate a large number of data points. A widely used method for hierarchical clustering of expression data is the quality cluster (QT) algorithm. A full description of this analytic method is available elsewhere (<xref ref-type="bibr" rid="bibr19-1099800411430380">Heyer, Kruglyak, &amp; Yooseph, 1999</xref>). Briefly, the QT algorithm clusters miRs into an unspecified number of groups based on pair-wise jackknife correlations<sup><xref ref-type="fn" rid="fn9-1099800411430380">
9
</xref></sup> between individual miRs. The QT clustering algorithm begins with a single miR signal and iteratively adds additional signals while minimizing the cluster diameter until no additional signals can be added without exceeding a predetermined cluster size. This process is repeated to develop additional clusters. A unique feature of QT clustering that makes it particularly appropriate for expression studies is the allowance of full iterative resampling of the data during the initial cluster assembly, in which signals already added to a cluster are still considered for successive clusters (<xref ref-type="bibr" rid="bibr19-1099800411430380">Heyer et al., 1999</xref>). At the completion of the initial clustering process, the largest cluster is removed from the data set, and the iterative process begins again with the remaining data to determine subsequent clusters.</p>
<p>At the completion of the analysis, a dendogram<sup><xref ref-type="fn" rid="fn10-1099800411430380">
10
</xref></sup> can be created to depict the clustering patterns of miR, and Venn diagrams<sup><xref ref-type="fn" rid="fn11-1099800411430380">
11
</xref></sup> can be used to describe how clusters compare between samples from comparative studies (<xref ref-type="fig" rid="fig4-1099800411430380">Figure 4</xref>
). Depiction of miR clustering patterns in Venn diagrams permit visualization of patterns of miR expression within phenotype groups. For example, <xref ref-type="bibr" rid="bibr22-1099800411430380">Ikeda et al. (2007)</xref> performed a microarray experiment measuring miR expression in cardiomyocytes of individuals with discrete mechanisms of heart failure (i.e., ischemic, dilated, aortic stenosis, and control). The aim of the study was to determine how miR expression clusters within phenotype groups and the extent to which miR expression differs between groups. The researchers created a dendogram clustering miR expression by phenotype from the heat map<sup><xref ref-type="fn" rid="fn12-1099800411430380">
12
</xref></sup> depicting up- and downregulation of each individual miR species. The dendogram shows which miRs are characteristic of each phenotype group and how individual miR species are coexpressed within phenotype groups, allowing for pattern detection. Similarly, the researcher created a Venn diagram in order to depict differential miR expression between phenotype groups and the extent to which individual miRs characterize discrete phenotypes.</p>
<fig id="fig4-1099800411430380" position="float">
<label>Figure 4.</label>
<caption>
<p>Venn diagram and dendogram. Graphic representation of clusters, or families, of microRNA species determined by clustering algorithms. Individual microRNA species are represented by letters, which either uniquely characterize clusters or are common to multiple clusters.</p>
</caption>
<graphic xlink:href="10.1177_1099800411430380-fig4.tif"/>
</fig>
</sec>
<sec id="section11-1099800411430380">
<title>Quantitative Prediction of miR Targets</title>
<p>MiRs are an abundant class of regulatory molecules arising from the genome. The number of miRs present for an individual species is poorly established, but most predictions for humans estimate that approximately 1,000 miRs are present. MiRs are nonspecific for their mRNA targets, and an individual miR species may bind with numerous mRNA species in order to regulate transcription. Determining which mRNA are bound by each miR has been the primary challenge to understanding the full cadre of functions of discrete miR species. Methods of computational prediction of mRNA targets based on miR nucleotide sequences have been successfully employed. Typically, these methods of computational prediction are experimentally validated for a subset of miR and mRNA pairs. Experimental validation studies yield estimates of specificity ranging from 50% to 80% (<xref ref-type="bibr" rid="bibr24-1099800411430380">John et al., 2004</xref>; <xref ref-type="bibr" rid="bibr27-1099800411430380">Krek et al., 2005</xref>; <xref ref-type="bibr" rid="bibr31-1099800411430380">Lewis, Shih, Jones-Rhoades, Bartel, &amp; Burge, 2003</xref>; <xref ref-type="bibr" rid="bibr46-1099800411430380">Rajewsky &amp; Socci, 2004</xref>; <xref ref-type="bibr" rid="bibr48-1099800411430380">Rehmsmeier, Steffen, Hochsmann, &amp; Giegerich, 2004</xref>). Several important features of both miR and mRNA have improved the capability of these computational prediction methods. The miR “seed,” composed of the nucleotides in positions 2–8 of the 5′ end of the miR, appears to be the most important miR region for target recognition (<xref ref-type="bibr" rid="bibr31-1099800411430380">Lewis et al., 2003</xref>). Binding sites on mRNA are often rich in the guanine and cytosine nucleotides, and mRNA regions rich in these nucleotides are more likely to contain miR binding sites (<xref ref-type="bibr" rid="bibr46-1099800411430380">Rajewsky &amp; Socci, 2004</xref>). Many genes appear to contain multiple miR binding sites for multiple miRs, and recent advances in computational prediction include identification of miR binding site clusters (<xref ref-type="bibr" rid="bibr27-1099800411430380">Krek et al., 2005</xref>; <xref ref-type="bibr" rid="bibr48-1099800411430380">Rehmsmeier et al., 2004</xref>). A comprehensive review of computational prediction of miR binding sites and methods for experimental validation is available elsewhere (<xref ref-type="bibr" rid="bibr8-1099800411430380">Chaudhuri &amp; Chatterjee, 2007</xref>).</p>
</sec>
</sec>
<sec id="section12-1099800411430380">
<title>Conclusions</title>
<p>Common, complex diseases arise in the setting of combined genetic and environmental risk, including gene–environment interactions. MiRs are an important form of epigenetic regulation of gene expression and function in animals, acting by altering protein synthesis in response to environmental changes. Measurement of miRs requires extraction of tissue from organs involved in the physiologic pathway of interest, preservation of tissue, and isolation of miRs from other genetic material. MiRs can be detected using a number of methods. Northern blot capitalizes on differences in size, shape, and/or charge of miRs to detect individual species hypothesized to be present in a tissue sample. Improving on the sensitivity and specificity of this method is PCR, which is an automated method for detecting miR species. Additional advantages of PCR are the ability to also quantify the number of miRs present in a sample and to perform multiplex analysis in which numerous experiments are run simultaneously. PCR experiments are performed in the setting of an a priori hypothesis for the presence of specific miR species in a tissue. Microarray has similar functions and advantages as PCR and is often used in hypothesis-free experiments to determine which miR species are present in a tissue.</p>
<p>Recent studies of miR activity in multiple disease conditions have yielded promising evidence for a regulatory role of miRs in the development and progression of disease. Clinical applications of miR measurement may enhance nursing practice by providing real time, personalized evaluation of individual health status, facilitating individualized treatment recommendations and assessment of the impact of nursing practice on individual and population health. However, implementation of this utility in humans using current techniques is largely limited by access to the organs involved in specific disease processes. However, preliminary data from studies of miR activity in blood plasma indicate that expression differences exist between diseased and healthy individuals. Accessing blood as a tissue source presents far fewer feasibility and ethical limitations and is routinely performed in clinical care and during health risk assessments. Additional studies are needed in order to determine the extent to which miR expression patterns in blood characterize specific disease processes. The dynamic nature of miR expression makes it an appealing target for early detection of an organism’s gene expression response to changes in its environment, and miR quantification holds promise not only as a target of therapeutic interventions but also as a measurement of response to interventions. Whether miR expression in blood from individuals with risk factors for disease is responsive to interventions targeted toward reducing risk remains to be explored.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn13-1099800411430380">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn14-1099800411430380">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for Elena Flowers' doctoral studies was provided by NIH/NIGMS R25 GM56847, NIH/NCRR/OD UCSF-CTSI Grant TL1 RR024129, Funding for Bradley E. Aouizerat was provided by, NIH/NCRR/OD UCSF-CTSI Grant Number KL2 RR024130.</p>
</fn>
</fn-group>
<notes>
<fn-group>
<title>Notes</title>
<fn fn-type="other" id="fn1-1099800411430380">
<label>1.</label>
<p>Involving changes in the phenotype or appearance of an organism that do not result from underlying changes to the genetic sequence.</p>
</fn>
<fn fn-type="other" id="fn2-1099800411430380">
<label>2.</label>
<p>Heat-catalyzed activation of a chemical reaction that emits a light signal.</p>
</fn>
<fn fn-type="other" id="fn3-1099800411430380">
<label>3.</label>
<p>Synthesized short strands of nucleic acids (generally &lt;20 nucleotides in length) designed to be used as probes that will bind to a specific cDNA or RNA sequence.</p>
</fn>
<fn fn-type="other" id="fn4-1099800411430380">
<label>4.</label>
<p>Nucleotide analogues that have undergone a conformational change to their sugar–phosphate backbone, making them extremely stable when bound to complementary strands.</p>
</fn>
<fn fn-type="other" id="fn5-1099800411430380">
<label>5.</label>
<p>A DNA polymerase originally cloned from the thermophilic bacteria <italic>Taq</italic>; stable at the high temperatures required for PCRs and functions by adding single nucleotides to a cDNA strand.</p>
</fn>
<fn fn-type="other" id="fn6-1099800411430380">
<label>6.</label>
<p>Primers that bind at the 5′ end of an RNA sequence, which is structurally the end of an RNA sequence compared to the 3′ beginning.</p>
</fn>
<fn fn-type="other" id="fn7-1099800411430380">
<label>7.</label>
<p>Short strands of nucleic acids that bind to mRNA to prevent translation.</p>
</fn>
<fn fn-type="other" id="fn8-1099800411430380">
<label>8.</label>
<p>Failing to detect a difference when one exists.</p>
</fn>
<fn fn-type="other" id="fn9-1099800411430380">
<label>9.</label>
<p>Calculated by a Pearson’s correlation coefficient between all data points except one, with iterative calculation of the coefficient after leaving out each data point in a data set. Jackknife correlations are robust to outliers and decrease the number of false-positive correlations.</p>
</fn>
<fn fn-type="other" id="fn10-1099800411430380">
<label>10.</label>
<p>Tree diagram depicting hierarchical relationships among clusters.</p>
</fn>
<fn fn-type="other" id="fn11-1099800411430380">
<label>11.</label>
<p>Circle diagram depicting theoretical relationships between clusters.</p>
</fn>
<fn fn-type="other" id="fn12-1099800411430380">
<label>12.</label>
<p>Graphical representation of data utilizing color to depict strength and magnitude of each variable.</p>
</fn>
</fn-group>
</notes>
<ref-list>
<title>References</title>
<ref id="bibr1-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allewell</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Sama</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>The effect of ammonium sulfate on the activity of ribonuclease A</article-title>. <source>Biochimica et Biophysica Acta</source>, <volume>341</volume>, <fpage>484</fpage>–<lpage>488</lpage>.</citation>
</ref>
<ref id="bibr2-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alwine</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Stark</surname>
<given-names>G. R.</given-names>
</name>
</person-group> (<year>1977</year>). <article-title>Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>74</volume>, <fpage>5350</fpage>–<lpage>5354</lpage>.</citation>
</ref>
<ref id="bibr3-1099800411430380">
<citation citation-type="web">
<collab collab-type="author">Ambion</collab>. (<year>2008a</year>). <source>mirVana miRNA isolation kit</source>. <comment>Retrieved November 7, 2009, from</comment> <ext-link ext-link-type="uri" xlink:href="http://www.ambion.com/techlib/prot/fm_1560.pdf">http://www.ambion.com/techlib/prot/fm_1560.pdf</ext-link>
</citation>
</ref>
<ref id="bibr4-1099800411430380">
<citation citation-type="web">
<collab collab-type="author">Ambion</collab>. (<year>2008b</year>). <source>RNAlater tissue collection: RNA stabilization solution</source>. <comment>Retrieved November 7, 2009, from</comment> <ext-link ext-link-type="uri" xlink:href="http://www.ambion.com/techlib/prot/bp_7020.pdf">http://www.ambion.com/techlib/prot/bp_7020.pdf</ext-link>
</citation>
</ref>
<ref id="bibr5-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bissels</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Wild</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tomiuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Holste</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hafner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tuschl</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bosio</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Absolute quantification of microRNAs by using a universal reference</article-title>. <source>RNA</source>, <volume>15</volume>, <fpage>2375</fpage>–<lpage>2384</lpage>.</citation>
</ref>
<ref id="bibr6-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Improved RNA preservation for immunolabeling and laser microdissection</article-title>. <source>RNA</source>, <volume>15</volume>, <fpage>2364</fpage>–<lpage>2374</lpage>.</citation>
</ref>
<ref id="bibr7-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Helenius</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lubovac</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Andren</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Klinga-Levan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues</article-title>. <source>Cancer Genetics and Cytogenetics</source>, <volume>202</volume>, <fpage>71</fpage>–<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr8-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhuri</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>MicroRNA detection and target prediction: Integration of computational and experimental approaches</article-title>. <source>DNA and Cell Biology</source>, <volume>26</volume>, <fpage>321</fpage>–<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr9-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ridzon</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Broomer</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname> Guegler</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Real-time quantification of microRNAs by stem-loop RT-PCR</article-title>. <source>Nucleic Acids Research</source>, <volume>33</volume>, <fpage>e179</fpage>.</citation>
</ref>
<ref id="bibr10-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname> Zhang</surname>
<given-names>C. Y.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases</article-title>. <source>Cell Research</source>, <volume>18</volume>, <fpage>997</fpage>–<lpage>1006</lpage>.</citation>
</ref>
<ref id="bibr11-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Korenberg</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Fogel</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Van Keuren</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname> Kurnit</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance</article-title>. <source>Genome Research</source>, <volume>6</volume>, <fpage>1013</fpage>–<lpage>1026</lpage>.</citation>
</ref>
<ref id="bibr12-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chomczynski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sacchi</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction</article-title>. <source>Analytical Biochemistry</source>, <volume>162</volume>, <fpage>156</fpage>–<lpage>159</lpage>.</citation>
</ref>
<ref id="bibr13-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dudley</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Aach</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Steffen</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Measuring absolute expression with microarrays with a calibrated reference sample and an extended signal intensity range</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>99</volume>, <fpage>7554</fpage>–<lpage>7559</lpage>.</citation>
</ref>
<ref id="bibr14-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Efron</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tibshirani</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Empirical Bayes methods and false discovery rates for microarrays</article-title>. <source>Genetic Epidemiology</source>, <volume>23</volume>, <fpage>70</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr15-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Florell</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Coffin</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Zimmermann</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Gerwels</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname> Leachman</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Preservation of RNA for functional genomic studies: A multidisciplinary tumor bank protocol</article-title>. <source>Modern Pathology</source>, <volume>14</volume>, <fpage>116</fpage>–<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr16-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>U. E.</given-names>
</name>
<name>
<surname>Heid</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>A novel method for real time quantitative RT-PCR</article-title>. <source>Genome Research</source>, <volume>6</volume>, <fpage>995</fpage>–<lpage>1001</lpage>.</citation>
</ref>
<ref id="bibr17-1099800411430380">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hartl</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E. W.</given-names>
</name>
</person-group> (<year>2005</year>). <source>Genetics: Analysis of genes and genomes</source>
<edition>6th ed</edition>.
<publisher-loc>Sudbury, MA</publisher-loc>: <publisher-name>Jones and Bartlett</publisher-name>.</citation>
</ref>
<ref id="bibr18-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heid</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Livak</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Real time quantitative PCR</article-title>. <source>Genome Research</source>, <volume>6</volume>, <fpage>986</fpage>–<lpage>994</lpage>.</citation>
</ref>
<ref id="bibr19-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heyer</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Kruglyak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yooseph</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Exploring expression data: Identification and analysis of coexpressed genes</article-title>. <source>Genome Research</source>, <volume>9</volume>, <fpage>1106</fpage>–<lpage>1115</lpage>.</citation>
</ref>
<ref id="bibr20-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hochberg</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Benjamini</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>More powerful procedures for multiple significance testing</article-title>. <source>Statistics in Medicine</source>, <volume>9</volume>, <fpage>811</fpage>–<lpage>818</lpage>.</citation>
</ref>
<ref id="bibr21-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holland</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gelfand</surname>
<given-names>D. H.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Detection of specific polymerase chain reaction product by utilizing the 5'–3’ exonuclease activity of Thermus aquaticus DNA polymerase</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>88</volume>, <fpage>7276</fpage>–<lpage>7280</lpage>.</citation>
</ref>
<ref id="bibr22-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bisping</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname> Pu</surname>
<given-names>W. T.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Altered microRNA expression in human heart disease</article-title>. <source>Physiological Genomics</source>, <volume>31</volume>, <fpage>367</fpage>–<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr23-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Gusev</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>T. D.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Real-time expression profiling of microRNA precursors in human cancer cell lines</article-title>. <source>Nucleic Acids Research</source>, <volume>33</volume>, <fpage>5394</fpage>–<lpage>5403</lpage>.</citation>
</ref>
<ref id="bibr24-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>John</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Enright</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Aravin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tuschl</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>D. S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Human microRNA targets</article-title>. <source>PLoS Biology</source>, <volume>2</volume>, <fpage>e363</fpage>.</citation>
</ref>
<ref id="bibr25-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kevil</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Laroux</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Kalogeris</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Grisham</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>An improved, rapid Northern protocol</article-title>. <source>Biochemical and Biophysical Research Communications</source>, <volume>238</volume>, <fpage>277</fpage>–<lpage>279</lpage>.</citation>
</ref>
<ref id="bibr26-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kloting</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Berthold</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schon</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Fasshauer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruschke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname> Bluher</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>MicroRNA expression in human omental and subcutaneous adipose tissue</article-title>. <source>PLoS One</source>, <volume>4</volume>, <fpage>e4699</fpage>.</citation>
</ref>
<ref id="bibr27-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Poy</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname> Rajewsky</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Combinatorial microRNA target predictions</article-title>. <source>Nature Genetics</source>, <volume>37</volume>, <fpage>495</fpage>–<lpage>500</lpage>.</citation>
</ref>
<ref id="bibr28-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krichevsky</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Donahue</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Khrapko</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kosik</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>A microRNA array reveals extensive regulation of microRNAs during brain development</article-title>. <source>RNA</source>, <volume>9</volume>, <fpage>1274</fpage>–<lpage>1281</lpage>.</citation>
</ref>
<ref id="bibr29-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagos-Quintana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rauhut</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yalcin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lendeckel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tuschl</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Identification of tissue-specific microRNAs from mouse</article-title>. <source>Current Biology</source>, <volume>12</volume>, <fpage>735</fpage>–<lpage>739</lpage>.</citation>
</ref>
<ref id="bibr30-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Yeung</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Livak</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Straus</surname>
<given-names>N. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Multiplexing RT-PCR for the detection of multiple miRNA species in small samples</article-title>. <source>Biochemical and Biophysical Research Communications</source>, <volume>343</volume>, <fpage>85</fpage>–<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr31-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Jones-Rhoades</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Burge</surname>
<given-names>C. B.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Prediction of mammalian microRNA targets</article-title>. <source>Cell</source>, <volume>115</volume>, <fpage>787</fpage>–<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr32-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Calin</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Meloon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gamliel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sevignani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ferracin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname> Croce</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>101</volume>, <fpage>9740</fpage>–<lpage>9744</lpage>.</citation>
</ref>
<ref id="bibr33-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>D. Z.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ander</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stamova</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname> Sharp</surname>
<given-names>F. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures</article-title>. <source>Journal of Cerebral Blood Flow and Metabolism</source>, <volume>30</volume>, <fpage>92</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr34-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kohane</surname>
<given-names>I. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Tissue and process specific microRNA-mRNA co-expression in mammalian development and malignancy</article-title>. <source>PLoS One</source>, <volume>4</volume>, <fpage>e5436</fpage>.</citation>
</ref>
<ref id="bibr35-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>T. D.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title>. <source>Methods</source>, <volume>25</volume>, <fpage>402</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr36-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lodes</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Caraballo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suciu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Munro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Detection of cancer with serum miRNAs on an oligonucleotide microarray</article-title>. <source>PLoS One</source>, <volume>4</volume>, <fpage>e6229</fpage>.</citation>
</ref>
<ref id="bibr37-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Humphreys</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Battah</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Rasko</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>PCR-based expression, analysis and identification of microRNAs</article-title>. <source>Journal of RNAi and Gene Silencing</source>, <volume>1</volume>, <fpage>44</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr38-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mraz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malinova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pospisilova</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>MicroRNA isolation and stability in stored RNA samples</article-title>. <source>Biochemical and Biophysical Research Communications</source>, <volume>390</volume>, <fpage>1</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr39-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullis</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Faloona</surname>
<given-names>F. A.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction</article-title>. <source>Methods in Enzymology</source>, <volume>155</volume>, <fpage>335</fpage>–<lpage>350</lpage>.</citation>
</ref>
<ref id="bibr40-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mutter</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Zahrieh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Neuberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Finkelstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Warrington</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays</article-title>. <source>BMC Genomics</source>, <volume>5</volume>, <fpage>88</fpage>.</citation>
</ref>
<ref id="bibr41-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neville</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Gloyn</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Karpe</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Comprehensive human adipose tissue mRNA and microRNA endogenous control selection for quantitative real-time-PCR normalization</article-title>. <source>Obesity (Silver Spring)</source>, <volume>19</volume>, <fpage>888</fpage>–<lpage>892</lpage>.</citation>
</ref>
<ref id="bibr42-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nolan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hands</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Bustin</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Quantification of mRNA using real-time RT-PCR</article-title>. <source>Nature Protocols</source>, <volume>1</volume>, <fpage>1559</fpage>–<lpage>1582</lpage>.</citation>
</ref>
<ref id="bibr43-1099800411430380">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Pagano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gauvreau</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2000</year>). <source>Principles of biostatistics</source>
<edition>2nd ed</edition>.
<publisher-loc>Australia; Pacific Grove, CA</publisher-loc>: <publisher-name>Duxbury</publisher-name>.</citation>
</ref>
<ref id="bibr44-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poy</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Eliasson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Krutzfeldt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuwajima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Macdonald</surname>
<given-names>P. E.</given-names>
</name>
<name>
<surname> Stoffel</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A pancreatic islet-specific microRNA regulates insulin secretion</article-title>. <source>Nature</source>, <volume>432</volume>, <fpage>226</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr45-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radom-Aizik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zaldivar</surname>
<given-names>F.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Oliver</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Galassetti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes</article-title>. <source>Journal of Applied Physiology</source>, <volume>109</volume>, <fpage>252</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr46-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajewsky</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Socci</surname>
<given-names>N. D.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Computational identification of microRNA targets</article-title>. <source>Developmental Biology</source>, <volume>267</volume>, <fpage>529</fpage>–<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr47-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raymond</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Garrett-Engele</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs</article-title>. <source>RNA</source>, <volume>11</volume>, <fpage>1737</fpage>–<lpage>1744</lpage>.</citation>
</ref>
<ref id="bibr48-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehmsmeier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Steffen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hochsmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giegerich</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Fast and effective prediction of microRNA/target duplexes</article-title>. <source>RNA</source>, <volume>10</volume>, <fpage>1507</fpage>–<lpage>1517</lpage>.</citation>
</ref>
<ref id="bibr49-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmittgen</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>A high-throughput method to monitor the expression of microRNA precursors</article-title>. <source>Nucleic Acids Research</source>, <volume>32</volume>, <fpage>e43</fpage>.</citation>
</ref>
<ref id="bibr50-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmittgen</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Zakrajsek</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Gorn</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>M. W.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: Comparison of endpoint and real-time methods</article-title>. <source>Analytical Biochemistry</source>, <volume>285</volume>, <fpage>194</fpage>–<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr51-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>V. L.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Facile means for quantifying microRNA expression by real-time PCR</article-title>. <source>Biotechniques</source>, <volume>39</volume>, <fpage>519</fpage>–<lpage>525</lpage>.</citation>
</ref>
<ref id="bibr52-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shingara</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Keiger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shelton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Laosinchai-Wolf</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Conrad</surname>
<given-names>R.</given-names>
</name>
<name>
<surname> Labourier</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>An optimized isolation and labeling platform for accurate microRNA expression profiling</article-title>. <source>RNA</source>, <volume>11</volume>, <fpage>1461</fpage>–<lpage>1470</lpage>.</citation>
</ref>
<ref id="bibr53-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Peralta</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Esau</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs</article-title>. <source>Nucleic Acids Research</source>, <volume>32</volume>, <fpage>e188</fpage>.</citation>
</ref>
<ref id="bibr54-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Armugam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sepramaniam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Setyowati</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Jeyaseelan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Expression profile of microRNAs in young stroke patients</article-title>. <source>PLoS One</source>, <volume>4</volume>, <fpage>e7689</fpage>.</citation>
</ref>
<ref id="bibr55-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hajkova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Lao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Surani</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>MicroRNA expression profiling of single whole embryonic stem cells</article-title>. <source>Nucleic Acids Research</source>, <volume>34</volume>, <fpage>e9</fpage>.</citation>
</ref>
<ref id="bibr56-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Muniappan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ozcan</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription</article-title>. <source>RNA</source>, <volume>15</volume>, <fpage>287</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr57-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valoczi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hornyik</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Burgyan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kauppinen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Havelda</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes</article-title>. <source>Nucleic Acids Research</source>, <volume>32</volume>, <fpage>e175</fpage>.</citation>
</ref>
<ref id="bibr58-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasilescu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tudor</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Veronese</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferracin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname> Calin</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis</article-title>. <source>PLoS One</source>, <volume>4</volume>, <fpage>e7405</fpage>.</citation>
</ref>
<ref id="bibr59-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinciguerra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sgroi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Veyrat-Durebex</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rubbia-Brandt</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Buhler</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Foti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes</article-title>. <source>Hepatology</source>, <volume>49</volume>, <fpage>1176</fpage>–<lpage>1184</lpage>.</citation>
</ref>
<ref id="bibr60-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>LeBlanc</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Abbruzzesse</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname> Sen</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease</article-title>. <source>Cancer Prevention Research</source>, <volume>2</volume>, <fpage>807</fpage>–<lpage>813</lpage>.</citation>
</ref>
<ref id="bibr61-1099800411430380">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray</article-title>. <source>Child’s Nervous System</source>, <volume>22</volume>, <fpage>1419</fpage>–<lpage>1425</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>